- Aug 29, 2023
- Jul 11, 2023
Zawiadomienie o rozstrzygnięciu postępowania
Zamawiający BioVentures Institute Sp. z o.o informuje, że w wyniku przeprowadzonego postępowania na usługę: Opracowanie technologii...
top of page
Recent news
Archived news
- Jul 11, 2023
ZAPYTANIE OFERTOWE
BioVentures Institute Sp. z o.o, jako podmiot realizujący projekt współfinansowany z Europejskiego Funduszu Rozwoju Regionalnego na...
30 views0 comments
- Jun 4, 2023
New publication in Critical Reviews in Microbiology
This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk,...
14 views0 comments
- Aug 3, 2022
New publication in Microorganisms
This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk,...
3 views0 comments
- Jan 28, 2022
New Publication in Microbial Cell Factories
This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk,...
3 views0 comments
- Oct 2, 2021
Grant from The National Centre for Research and Development
The National Centre for Research and Development grant TECHMATSTRATEG2/410747/11/NCBR/2019 (2019-2022) to the Consortium led by...
49 views0 comments
- Jul 2, 2021
Bacteriophages of Thermophilic ‘Bacillus Group’Bacteria—A Review
The publication reviewing potential and used by BioVentures Institute thermophilic bacteriophages and Virus-Like-Particles (VLPs)...
35 views0 comments
- Jun 21, 2021
Positive initial animal trials of the recombinant anti-SARS-CoV-2 vaccine
The vaccine has been purified, analysed using a number of techniques, including electrophoresis, LC-MS, Western blotting and was...
36 views0 comments
- Apr 2, 2021
Development of a novel type of recombinant anti-SARS-CoV-2 vaccine
The DNA-FACE™ concept of construction of ‘artificial’, concatemeric protein with a vaccine functionality has been used to construct an...
43 views0 comments
- Mar 9, 2021
Patent in Israel granted for DNA-FACE™
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
54 views0 comments
- Dec 31, 2020
Patent in US granted for DNA-FACE™
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
67 views0 comments
- Nov 2, 2020
Funds from The National Centre for Research and Development
The National Centre for Research and Development grant TECHMATSTRATEG-III/0042/2019 (2020-2023) received by the Institute...
94 views0 comments
- Aug 28, 2020
Patent for EU
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
27 views0 comments
- Aug 21, 2020
New publication in MethodsX international journal
Detailed laboratory protocols, concerning the patented BioVentures Institute genetic engineering and protein functional programming,...
35 views0 comments
- Aug 5, 2020
Patent for China
We have been informed by Chineese Patent Office that our patent application no 201580028495.1, concerning our break-through recombinant...
13 views0 comments
- Jul 2, 2020
Patent in US granted for DNA-FACE™
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
10 views0 comments
- Jun 24, 2020
Scientific publication
Scientific publication in the area of industrial enzymes. A novel proteinase Onygena, an improved alternative to the ‘workhorse’ of...
10 views0 comments
- May 29, 2020
Patent for Israel
We have been informed by Israeli Patent Office that our patent application no 248011, concerning our break-through recombinant DNA...
12 views0 comments
- Apr 17, 2020
Patent for Japan
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
11 views0 comments
- Mar 20, 2020
Patent application for India
We have been informed by Indian Patent Office that our patent application no 201647039411, concerning our break-through recombinant DNA...
11 views0 comments
- Dec 31, 2019
New publication in Data in Brief international journal
More technical details, concerning the patented BioVentures Institute genetic engineering and protein functional programming,...
12 views0 comments
- Nov 13, 2019
New publication in Materials Science & Engineering C
The patented BioVentures Institute genetic engineering and protein functional programming, construction and biosynthesis technology,...
15 views0 comments
- Aug 3, 2018
Patent for Republic of Poland
Our break-through recombinant DNA biotechnology for the construction of new generation vaccines, biologics, biosymilars, industrial and...
9 views0 comments
- Apr 6, 2018
New scientific publication
New scientific publication, defining a new bacteriophage genus TP84 virus. The paper describes monographic work on TP-84 bacteriophage...
13 views0 comments
- Nov 13, 2017
Establishing CLEARWING FOUNDATION FOR BIODIVERSITY
Our company and team members are environmentally conscious. BioVentures Institute’s patented technology has a potentially high impact on...
34 views0 comments
- Jul 27, 2017
ClearWing Foundation for Biodiversity
Our company and team members are environmentally conscious. BioVentures Institute patented technology has potentially high impact on the...
11 views0 comments
- Jul 2, 2017
Cooperation with University of Gdansk and New England Biolabs Ltd. (USA)
BioVentures InstituteSp. z o.o. continues a long term cooperation with University of Gdansk and New England Biolabs Ltd. (USA), a world...
15 views0 comments
- Jan 2, 2017
The new grant issued
The new grant STRATEGMED TARGETTELO in the amount of 19 654 385.00 PLN issued by the National Center for Research and Development was...
12 views0 comments
- Nov 2, 2016
Patent application to USA, EU, Israel, Japan, China, India
BioVentures Institute Sp. z o.o. has extended the international PCT patent application no WO 2015162560 A1, covering the technology of...
8 views0 comments
- Feb 8, 2016
Business relationship with Israeli companies
BioVentures Institute established business relationships with several Israeli companies, as well as with the Israeli Ministry of Regional...
10 views0 comments
- Feb 2, 2016
New “molecular scissors” for DNA cleavage
Cooperation in the area of engineering of enzyme performance for biotechnology purposes between BioVentures Institute Sp. z o. o. and ...
12 views0 comments
- Oct 19, 2015
Cooperation agreement with Barentzymes AS
Barentzymes AS, a Norwegian biotechnology company (part of Fluenta holding) has signed a long term cooperation agreement with BioVentures...
11 views0 comments
- Jun 2, 2015
Professor Piotr Skowron received the 1st award
Professor Piotr Skowron received the 1st award granted by the Pomeranian Employers Association in the category “Primum Cooperatio” i.e....
11 views0 comments
- Apr 21, 2015
New patent application
BioVentures Institute Sp. z o.o. filed an international patent application (PCT). Title of application: „A method of obtaining a...
13 views0 comments
- Mar 2, 2015
Funds established
In cooperation with the University of Gdańsk, BioVentures Institute Sp. z o.o. has established funds and applied research programmes for...
7 views0 comments
- Oct 2, 2014
Cooperation with the University of Gdansk
Scientists from BioVentures Institute Sp. z o.o. continue their cooperation with theUniversity of Gdansk in the area of regenerative...
9 views0 comments
- Jul 2, 2014
Piotr Skowron has received professor title in biological sciences.
Piotr Skowron received the professor title in biological sciences. On July 28th, after receiving positive reviews and a decision from...
14 views0 comments
- Jan 2, 2014
The cooperation in the area of gene cloning and engineering of enzymes
Cooperation in the area of gene cloning and engineering of enzymes for biotechnology applications between BioVentures Institute Sp. z...
15 views0 comments
- Dec 2, 2013
SATUS Venture Capital and Jagiellonian Centre of Innovation (JCI)
BioVentures Institute Sp. z o.o. has accepted a venture capital entry by SATUS Venture Capital and Jagiellonian Centre of Innovation...
7 views0 comments
- Aug 2, 2013
The scientific cooperation
The ongoing scientific cooperation between BioVentures Institute Sp. z o.o., Thermo Fisher Scientific and Department of Molecular...
15 views0 comments
- Jun 5, 2013
Funds established
INVESTIN programme in cooperation with BioVentures Institute Sp. z o.o. has established two funds for advanced molecular biotechnology...
9 views0 comments
- Oct 2, 2012
BioVentures Institute Sp. z o.o. received funding from the European Union (EU)
BioVentures Institute Sp. z o.o. received funding from the European Union (EU) via the National Centre for Research and Development...
18 views0 comments
- Apr 2, 2012
The scientific cooperation
The scientific cooperation between BioVentures Institute Sp. z o.o., Thermo Fisher Scientific and Department of Environmental Molecular...
12 views0 comments
- Mar 2, 2012
Research affiliation
Research affiliation between BioVentures Institute Sp. z o.o. and Department of Hepatology and Acquired Immunodeficiency, Medical...
13 views0 comments
- Nov 2, 2011
Thermo Fisher Scientific - long term research cooperation
Long term research cooperation agreement in the field of molecular biotechnology has been signed between BioVentures Institute Sp. z o.o....
9 views0 comments
bottom of page